03448cam a22004218i 450000100090000000300080000900500170001700700030003400800410003701000170007802000180009502000150011304000230012804100080015104200080015904300210016705000250018810000250021324501040023825000190034226400520036130000260041333600260043933700280046533800270049350400510052050503520057152017350092365000420265865000380270065000390273865000370277790600450281494200120285994600090287199900190288095201270289922904713BJBSDDR20241113093037.0ta221217s2023    nyu      b    001 0 eng    a  2022057318  z9780393540956  z0393540952  aDLCbengerdacDLC  aeng  apcc  an-us---an-us-ca14aHD 9999 bV291f 20231 aVardi, Nathan93931610aFor blood and money :bbillionaires, biotech, and the quest for a blockbuster drug /cNathan Vardi.  aFirst edition. 1aNew York, N.Y. :bW.W. Norton & Company,c2023   a271 pages ; c24 cm.   atextbtxt2rdacontent  aunmediatedbn2rdamedia  avolumebnc2rdacarrier  aIncludes bibliographical references and index.0 aPrologue : sidelines -- The surfing Scientologist -- Man of science -- The takeover -- Starting fresh -- Wall Street -- The Big Easy -- The next phase -- Fired -- Partners -- Going Dutch -- Genius -- Truffle pig -- Master switch -- Approved -- Demoted -- Billions -- The whirlwind -- A biotech odyssey -- Graduation day -- Epilogue : head-to-head.  a"For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team-denied their share of the profits-went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks-and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they're onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi's narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it's so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine"--cProvided by publisher. 0aBiotechnology industrieszCalifornia. 4aIndustria biotecnológica 99731 4aBiotecnología industrial 939471 0aDrug developmentzUnited States.  a7bcbccorignewd1eecipf20gy-gencatlg  2lcccBK  idpf   c122375d122375  00102lcc40708CSaBJBbBJBcCSd2024-10-31l0oHD 9999  V291f 2023p00000186689r2024-10-31 00:00:00t1w2024-10-31yBK